FDA Inspection 1202279 — H. Henry Li, MD

H. Henry Li, MD — FEI 3012725427

The FDA completed an inspection of H. Henry Li, MD on March 24, 2023 in Chevy Chase, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chevy Chase, MD (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
736721 CFR 50.55(e)(2)Two parents' permission: studies under Parts 50.53 - 50.54